In line with this observation, the downstream mTORC1 activity has been reported to be transcriptionally upregulated by ERK in KRAS mutant CRC cells, thereby causing resistance to PI3K and Akt inhibitors18. The gene discussed is KRAS; the disease is colorectal carcinoma.